Verastem Future Growth
Future criteria checks 0/6
Verastem is forecast to grow earnings and revenue by 49.6% and 57.7% per annum respectively while EPS is expected to grow by 52.6% per annum.
Key information
49.6%
Earnings growth rate
52.6%
EPS growth rate
Biotechs earnings growth | 31.1% |
Revenue growth rate | 57.7% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 11 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 102 | -55 | -82 | -113 | 6 |
12/31/2025 | 31 | -117 | -107 | -117 | 7 |
12/31/2024 | N/A | -130 | -121 | -121 | 7 |
12/31/2023 | N/A | -87 | -86 | -86 | N/A |
9/30/2023 | N/A | -77 | -73 | -73 | N/A |
6/30/2023 | N/A | -75 | -72 | -72 | N/A |
3/31/2023 | N/A | -73 | -65 | -65 | N/A |
12/31/2022 | 3 | -74 | -64 | -64 | N/A |
9/30/2022 | 3 | -73 | -57 | -57 | N/A |
6/30/2022 | 3 | -78 | -53 | -53 | N/A |
3/31/2022 | 4 | -73 | -53 | -53 | N/A |
12/31/2021 | 2 | -71 | -54 | -54 | N/A |
9/30/2021 | 2 | -75 | -65 | -65 | N/A |
6/30/2021 | 81 | -39 | -10 | -10 | N/A |
3/31/2021 | 84 | -45 | -19 | -19 | N/A |
12/31/2020 | 89 | -68 | -34 | -34 | N/A |
9/30/2020 | 92 | -87 | -49 | -49 | N/A |
6/30/2020 | 22 | -130 | -122 | -122 | N/A |
3/31/2020 | 21 | -149 | -134 | -134 | N/A |
12/31/2019 | 17 | -149 | -139 | -139 | N/A |
9/30/2019 | 15 | -122 | -143 | -120 | N/A |
6/30/2019 | 22 | -113 | -138 | -115 | N/A |
3/31/2019 | 28 | -89 | -114 | -91 | N/A |
12/31/2018 | 27 | -72 | -98 | -75 | N/A |
9/30/2018 | 26 | -79 | -77 | -76 | N/A |
6/30/2018 | 10 | -81 | -66 | -65 | N/A |
3/31/2018 | N/A | -76 | -69 | -69 | N/A |
12/31/2017 | N/A | -68 | -57 | -57 | N/A |
9/30/2017 | N/A | -61 | N/A | -43 | N/A |
6/30/2017 | N/A | -46 | N/A | -37 | N/A |
3/31/2017 | N/A | -41 | N/A | -29 | N/A |
12/31/2016 | N/A | -36 | N/A | -29 | N/A |
9/30/2016 | N/A | -37 | N/A | -34 | N/A |
6/30/2016 | N/A | -44 | N/A | -39 | N/A |
3/31/2016 | N/A | -51 | N/A | -45 | N/A |
12/31/2015 | N/A | -58 | N/A | -46 | N/A |
9/30/2015 | N/A | -60 | N/A | -45 | N/A |
6/30/2015 | N/A | -58 | N/A | -43 | N/A |
3/31/2015 | N/A | -55 | N/A | -39 | N/A |
12/31/2014 | N/A | -53 | N/A | -37 | N/A |
9/30/2014 | N/A | -51 | N/A | -34 | N/A |
6/30/2014 | N/A | -48 | N/A | -32 | N/A |
3/31/2014 | N/A | -45 | N/A | -29 | N/A |
12/31/2013 | N/A | -41 | N/A | -26 | N/A |
9/30/2013 | N/A | -38 | N/A | -26 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 2VSA is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 2VSA is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 2VSA is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 2VSA is forecast to have no revenue next year.
High Growth Revenue: 2VSA is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 2VSA's Return on Equity is forecast to be high in 3 years time